Skip to main content

Table 2 Incidence of CRBSI in the vancomycin-lock and control groups

From: Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants

  Vancomycin-lock group (n = 68) Control group (n = 69) RR (95%CI) p value
CRBSI n (%) 3 (4.4%) 15 (21.7%) 0.20 (0.06–0.67) 0.004
Confirmed n (%) 3 (4.4%) 11 (15.9%) 0.28 (0.08–0.95) 0.045
Suspected n (%) 0 4 (5.8%) 0.11 (0.01–2.05) 0.120
  1. Note: CBRSI included the confirmed and suspected cases